Meiogenix engages in chromosome editing to develop innovative products. It aims to expand the biodiversity that can be used by farmers to address global climate, sustainability, and food challenges by unlocking the natural genetic diversity of crops. Meiogenix’s technology enables the targeting of homologous recombination in plant genomes, allowing the re-assembly of traits during the breeding process. Meanwhile, Meiogenix product development, which is based on the natural process of recombination, reduces lengthy breeding cycles and allows the development of entirely new complex traits or natural biodiversity. Headquartered in France, Meiogenix is privately held and has operations in the US.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.